Use of the QuantiFERON® -TB Gold test for screening tuberculosis contacts and predicting active disease

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 7, 2010, Pages 819-827

  Yoshiyama, Takashi ^a   Harada, N ^b   Higuchi, K ^b   Sekiya, Y ^b   Uchimura, K ^b  

^a Japan Anti Tuberculosis Association   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Prediction; Progression to TB disease; QuantiFERON TB gold; Tuberculosis

Indexed keywords

ISONIAZID; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTACT EXAMINATION; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; FEMALE; FOLLOW UP; GOLD STANDARD; HEALTH CENTER; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUANTIFERON TB GOLD TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SCREENING TEST; SENSITIVITY ANALYSIS; TREATMENT DURATION; TUBERCULIN TEST; INFANT; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTERFERON-GAMMA; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 77953640004     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. US Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. MMWR 2005; 54(RR15): 1-37.
2. National Institute for Clinical Excellence. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: NICE, 2006. http://www.nice.org.uk/page.aspx?o=CG033 Accessed April 2010.
3. Ishikawa N, Ahiko T, Mori T. Guidelines for the contact investigations upon the revised infection control law. Tokyo, Japan: Japan Anti-Tuberculosis Association, 2007.
4. Andersen P, Munk M E, Pollock J M, Doherty T M. Specifi c immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
5. US Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON® -TB Gold Test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54(RR-15): 49-55.
6. Prevention Committee, Japanese Society of Tuberculosis. [Guidelines for the use of QuantiFERON® TB-2G.] Kekkaku 2006; 81: 393-397. [Japanese]
7. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
8. Diel R, Loddenkemper R, Meywald-Water K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Crit Care Med 2008; 177: 1164-1170.
9. Aichelburg M C, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood i nterferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.
10. Bakir M, Millington K A, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149: 777-787.
11. Hill P C, Jackson-Sillah D J, Fox A, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008; 3: e1379.
12. Kik S V, Franken W P, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2009 (in press).
13. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERONTB Gold to investigate tuberculosis contacts in a high school. Respirology 2007; 12: 88-92.
14. Higuchi K, Kondo S, Wada M, et al. Contact investigation in a primary school using a whole blood interferon-gamma assay. J Infect 2009; 58: 352-357.
15. Yamaguchi J, Ooba Y, Kaneda M, et al. [Outbreak of pulmonary tuberculosis in which tuberculosis developed from Quanti- FERON® TB-2G test negative persons.] Kekkaku 2007; 82: 629-634. [Japanese]
16. Miyashita Y, Higuchi K, Higashiyama N, et al. [Detection of tuberculosis infection using a whole blood interferon gamma assay in a contact investigation.] Kekkaku 2005; 80: 557-565. [Japanese]
17. Farebee S H. Controlled chemoprophylaxis trials in tuberculosis, a general review. Adv Tuberc Res 1970; 17: 28-106.
18. Funayama K, Tsujimoto A, Mori M, et al. [Usefulness of Quanti- FERON® TB-2G in contact investigation of a tuberculosis outbreak in a university.] Kekkaku 2005; 80: 527-534. [Japanese]
19. Fukazawa K. [Application and problems of QuantiFERON® TB- 2G for tuberculosis control programs (1) tuberculosis outbreak in a cram school.] Kekkaku 2007; 82: 53-59. [Japanese]
20. Higuchi K, Harada N, Nagasaka Y, Mori T. [Analysis of tuberculosis infection among foreigners using QuantiFERON® TB- 2G test.] Kekkaku 2007; 82: 515-521. [Japanese]
21. Kimura M, Comstock G W, Mori T. Comparison of erythema and induration as results of tuberculin tests. Int J Tuberc Lung Dis 2005; 9: 853-857.
22. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood i nterferon-γ and Mantoux testing among Japanese healthcare workers. Infect Cont Hosp Epidemiol 2006; 27: 442-448.
23. Cellestis Ltd. QuantiFERON® TB-Gold. Carnegie, VIC, Australia: Cellestis Ltd, 2010. http://www.cellestis.com/IRM/Content/ usa/gftproducts- tbgold-techninfo.htm Accessed April 2010.
24. Yoshiyama T, Harada N, Higuchi K, Ogata H. [Timing of QuantiFERON® TB-G for the contact examination of tuberculosis.] Kekkaku 2007; 82: 655-658. [Japanese]
25. Harada N, Higuchi K, Sekiya Y, Rothel J, Kito T, Mori T. [Basic characteristics of a novel diagnostic method (QuantiFERON® - TB-2G) of latent tuberculosis infection with a use of Mycobacterium tuberculosis-specifi c antigens, ESAT-6 and CFP-10.] Kekkaku 2004; 79: 725-735. [Japanese]